Recordati SpA (RICFY)
12.79
+0.01
(+0.08%)
USD |
OTCM |
Jun 09, 16:00
Recordati 1 Year Total Returns (Daily) : -15.46% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | -15.46% |
| June 08, 2026 | -15.66% |
| June 05, 2026 | -0.41% |
| June 04, 2026 | -0.41% |
| June 03, 2026 | -1.42% |
| June 02, 2026 | 3.46% |
| June 01, 2026 | 3.46% |
| May 29, 2026 | 3.50% |
| May 28, 2026 | 3.50% |
| May 27, 2026 | -12.96% |
| May 26, 2026 | -4.68% |
| May 22, 2026 | -26.18% |
| May 21, 2026 | -26.18% |
| May 20, 2026 | -23.42% |
| May 19, 2026 | -22.45% |
| May 18, 2026 | -23.27% |
| May 15, 2026 | -11.43% |
| May 14, 2026 | -8.76% |
| May 13, 2026 | -10.33% |
| May 12, 2026 | -10.33% |
| May 11, 2026 | -10.33% |
| May 08, 2026 | 11.70% |
| May 07, 2026 | 11.70% |
| May 06, 2026 | 11.70% |
| May 05, 2026 | 7.22% |
| Date | Value |
|---|---|
| May 04, 2026 | 14.46% |
| May 01, 2026 | 15.95% |
| April 30, 2026 | 15.95% |
| April 29, 2026 | -14.71% |
| April 28, 2026 | -13.33% |
| April 27, 2026 | -10.93% |
| April 24, 2026 | -10.93% |
| April 23, 2026 | 4.82% |
| April 22, 2026 | 4.82% |
| April 21, 2026 | 8.58% |
| April 20, 2026 | 6.52% |
| April 17, 2026 | -11.13% |
| April 16, 2026 | -9.83% |
| April 15, 2026 | -9.83% |
| April 14, 2026 | -11.98% |
| April 13, 2026 | -13.09% |
| April 10, 2026 | -4.76% |
| April 09, 2026 | 18.50% |
| April 08, 2026 | -6.82% |
| April 07, 2026 | -10.07% |
| April 06, 2026 | 2.40% |
| April 02, 2026 | 5.17% |
| April 01, 2026 | -16.73% |
| March 31, 2026 | -17.72% |
| March 30, 2026 | -0.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| DiaSorin SpA | -17.85% |
| AbbVie, Inc. | 23.08% |
| Abeona Therapeutics, Inc. | -16.67% |
| Ascentage Pharma Group International Co., Ltd. | -42.87% |
| Aardvark Therapeutics, Inc. | -69.35% |